Stock listing

Heron Therapeutics, Inc.

Selected listing: HRTX · NASDAQ · USD · US

Heron Therapeutics, Inc. (NASDAQ:HRTX), Health Technology. Latest release Aug 10, 2026: Heron Therapeutics Announces Second Quarter 2026 Financial Results.

HRTX:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:HRTX
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Heron Therapeutics, Inc.

The company focuses on developing innovative therapeutics to improve patient outcomes. Heron is committed to advancing its product pipeline and addressing unmet medical needs in various therapeutic areas.

Latest news from Heron Therapeutics, Inc.

Heron Therapeutics Announces Second Quarter 2026 Financial Results

August 10, 2026

Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026

July 27, 2026

U.S. District Court Issues Decision Regarding CINVANTI® Patents

June 1, 2026

Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

May 11, 2026

Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026

April 27, 2026

All Heron Therapeutics, Inc. news →

Events

Replays

Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call
Mon, Aug 10, 2026 · 08:30 AM ET
Watch
Heron Therapeutics, Inc. (HRTX) Q1 2026 Earnings Call
Mon, May 11, 2026 · 08:30 AM ET
Watch
Heron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call
Thu, Feb 26, 2026 · 08:30 AM ET
Watch

Research Heron Therapeutics, Inc.

Heron Therapeutics, Inc. company profile

View the public company page for Heron Therapeutics, Inc. on 6ix.

Heron Therapeutics, Inc. news

Read company news and market updates connected to Heron Therapeutics, Inc..

Heron Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Heron Therapeutics, Inc..